PATENT CLAIM ANALYSIS

Application Number: 15769223
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "282000"]

Abstract:
The purpose of the present invention is to provide a compound useful as a prophylactic or therapeutic agent for various diseases and symptoms related to orexin receptors, and a medical usage of the same. The present invention provides a morphinan derivative represented by the general formula (I) below or a pharmaceutically acceptable acid addition salt thereof, the morphinan derivative having excellent selectivity for and antagonism against orexin receptors and excellent therapeutic and prophylactic effects on drug dependence, and an orexin receptor antagonist and a therapeutic or prophylactic agent for drug dependence each containing it as an active ingredient.

Claim (Index 2):
The morphinan derivative or the pharmaceutically acceptable acid addition salt thereof according to  claim 1 , wherein L 1 -L 2 -L 3  represents C(R 9 )\u2014CH 2 \u2014CH 2  (where R 9  has the same definition as above) or C\u2550CH\u2014CH 2 , and wherein R 5  and R 6  together represent \u2014O\u2014.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 91.0
- Lexical Diversity: 1.64062
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14343218', '14772188', '10530664', '15558026', '11736064']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7703254731175356
- 35 USC 102 Novelty (BERT): 0.5410845485247036
- Combined Prediction Score: 0.7474013806582525
- Mean Citation Score: 314.99592799999994
- Max Citation Score: 366.32556
- Similarity Product: 304.644178163023

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test